Back to GILD
VANGUARD GROUP INC GILD Position History
Gilead Sciences, Inc. • Healthcare
Quarters held
24
Latest value
$334.9M
Q4 2025
Peak value
$13.3B
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $233.8M |
| Q1 2025 | $12.5B |
| Q1 2025 | $63M |
| Q1 2025 | $210K |
| Q1 2025 | $85M |
| Q1 2025 | $296.6M |
| Q2 2025 | $244.8M |
| Q2 2025 | $12.5B |
| Q2 2025 | $64.7M |
| Q2 2025 | $208K |
| Q2 2025 | $85.9M |
| Q2 2025 | $299.4M |
| Q3 2025 | $731.5M |
| Q3 2025 | $301.2M |
| Q3 2025 | $11.9B |
| Q3 2025 | $252.8M |
| Q3 2025 | $66M |
| Q3 2025 | $208K |
| Q4 2025 | $284.6M |
| Q4 2025 | $13.3B |
| Q4 2025 | $74.8M |
| Q4 2025 | $290K |
| Q4 2025 | $857.2M |
| Q4 2025 | $334.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $334.9M | 2.73M | — | — |
| Q4 2025 | $857.2M | 6.98M | — | — |
| Q4 2025 | $290K | 2.4K | — | — |
| Q4 2025 | $74.8M | 609.3K | — | — |
| Q4 2025 | $13.3B | 108.45M | — | — |
| Q4 2025 | $284.6M | 2.32M | — | — |
| Q3 2025 | $208K | 1.9K | — | — |
| Q3 2025 | $66M | 595.0K | — | — |
| Q3 2025 | $252.8M | 2.28M | — | — |
| Q3 2025 | $11.9B | 106.81M | — | — |
| Q3 2025 | $301.2M | 2.71M | — | — |
| Q3 2025 | $731.5M | 6.59M | — | — |
| Q2 2025 | $299.4M | 2.70M | — | — |
| Q2 2025 | $85.9M | 774.5K | — | — |
| Q2 2025 | $208K | 1.9K | — | — |
| Q2 2025 | $64.7M | 583.2K | — | — |
| Q2 2025 | $12.5B | 113.10M | — | — |
| Q2 2025 | $244.8M | 2.21M | — | — |
| Q1 2025 | $296.6M | 2.65M | — | — |
| Q1 2025 | $85M | 759.0K | — | — |
| Q1 2025 | $210K | 1.9K | — | — |
| Q1 2025 | $63M | 562.6K | — | — |
| Q1 2025 | $12.5B | 111.41M | — | — |
| Q1 2025 | $233.8M | 2.09M | — | — |
Other funds holding GILD
$8.3B
$7.7B
$7.7B
$7.4B
$6.7B
$6.6B
$6.6B
$5.6B